171 related articles for article (PubMed ID: 24608966)
1. High frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants.
Nome T; Hoff AM; Bakken AC; Rognum TO; Nesbakken A; Skotheim RI
PLoS One; 2014; 9(3):e91264. PubMed ID: 24608966
[TBL] [Abstract][Full Text] [Related]
2. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
Bass AJ; Lawrence MS; Brace LE; Ramos AH; Drier Y; Cibulskis K; Sougnez C; Voet D; Saksena G; Sivachenko A; Jing R; Parkin M; Pugh T; Verhaak RG; Stransky N; Boutin AT; Barretina J; Solit DB; Vakiani E; Shao W; Mishina Y; Warmuth M; Jimenez J; Chiang DY; Signoretti S; Kaelin WG; Spardy N; Hahn WC; Hoshida Y; Ogino S; DePinho RA; Chin L; Garraway LA; Fuchs CS; Baselga J; Tabernero J; Gabriel S; Lander ES; Getz G; Meyerson M
Nat Genet; 2011 Sep; 43(10):964-968. PubMed ID: 21892161
[TBL] [Abstract][Full Text] [Related]
3. The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2.
Davidsen J; Larsen S; Coskun M; Gögenur I; Dahlgaard K; Bennett EP; Troelsen JT
PLoS One; 2018; 13(7):e0200215. PubMed ID: 29975781
[TBL] [Abstract][Full Text] [Related]
4. Novel RNA variants in colorectal cancers.
Hoff AM; Johannessen B; Alagaratnam S; Zhao S; Nome T; Løvf M; Bakken AC; Hektoen M; Sveen A; Lothe RA; Skotheim RI
Oncotarget; 2015 Nov; 6(34):36587-602. PubMed ID: 26474385
[TBL] [Abstract][Full Text] [Related]
5. Loss of the nuclear Wnt pathway effector TCF7L2 promotes migration and invasion of human colorectal cancer cells.
Wenzel J; Rose K; Haghighi EB; Lamprecht C; Rauen G; Freihen V; Kesselring R; Boerries M; Hecht A
Oncogene; 2020 May; 39(19):3893-3909. PubMed ID: 32203164
[TBL] [Abstract][Full Text] [Related]
6. Cumulative evidence for relationships between multiple variants in the VTI1A and TCF7L2 genes and cancer incidence.
Zhang M; Tang M; Fang Y; Cui H; Chen S; Li J; Xiong H; Lu J; Gu D; Zhang B
Int J Cancer; 2018 Feb; 142(3):498-513. PubMed ID: 28949031
[TBL] [Abstract][Full Text] [Related]
7. Recurrent read-through fusion transcripts in breast cancer.
Varley KE; Gertz J; Roberts BS; Davis NS; Bowling KM; Kirby MK; Nesmith AS; Oliver PG; Grizzle WE; Forero A; Buchsbaum DJ; LoBuglio AF; Myers RM
Breast Cancer Res Treat; 2014 Jul; 146(2):287-97. PubMed ID: 24929677
[TBL] [Abstract][Full Text] [Related]
8. Gene variants of TCF7L2 are histopathologically important in colorectal cancers but do not have direct association with MYC expression.
Ozkan Kucuk NE; Horozoglu C; Timirci Kahraman O; Arikan S; Farooqi AA; Turan S; Korkmaz G; Kelten Talu EC; Sabitaliyevich UY; Yaylim I
Cell Mol Biol (Noisy-le-grand); 2019 Dec; 65(8):1-6. PubMed ID: 32133972
[TBL] [Abstract][Full Text] [Related]
9. Cryptic splice site activation during RNA processing of MLL/AF4 chimeric transcripts in infants with t(4;11) positive ALL.
Divoky V; Trka JM; Watzinger F; Lion T
Gene; 2000 Apr; 247(1-2):111-8. PubMed ID: 10773450
[TBL] [Abstract][Full Text] [Related]
10. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
[TBL] [Abstract][Full Text] [Related]
11. Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes.
Hansson O; Zhou Y; Renström E; Osmark P
Curr Diab Rep; 2010 Dec; 10(6):444-51. PubMed ID: 20878273
[TBL] [Abstract][Full Text] [Related]
12. Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing.
Nome T; Thomassen GO; Bruun J; Ahlquist T; Bakken AC; Hoff AM; Rognum T; Nesbakken A; Lorenz S; Sun J; Barros-Silva JD; Lind GE; Myklebost O; Teixeira MR; Meza-Zepeda LA; Lothe RA; Skotheim RI
Transl Oncol; 2013; 6(5):546-53. PubMed ID: 24151535
[TBL] [Abstract][Full Text] [Related]
13. TCF7L2 splice variants have distinct effects on beta-cell turnover and function.
Le Bacquer O; Shu L; Marchand M; Neve B; Paroni F; Kerr Conte J; Pattou F; Froguel P; Maedler K
Hum Mol Genet; 2011 May; 20(10):1906-15. PubMed ID: 21357677
[TBL] [Abstract][Full Text] [Related]
14. BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line.
Morrison A; Chekaluk Y; Bacares R; Ladanyi M; Zhang L
PLoS One; 2015; 10(4):e0119224. PubMed ID: 25830670
[TBL] [Abstract][Full Text] [Related]
15. Identification of FERM domain-containing protein 5 as a novel target of β-catenin/TCF7L2 complex.
Zhu C; Yamaguchi K; Ohsugi T; Terakado Y; Noguchi R; Ikenoue T; Furukawa Y
Cancer Sci; 2017 Apr; 108(4):612-619. PubMed ID: 28117551
[TBL] [Abstract][Full Text] [Related]
16. Fusion transcript loci share many genomic features with non-fusion loci.
Lai J; An J; Seim I; Walpole C; Hoffman A; Moya L; Srinivasan S; Perry-Keene JL; ; Wang C; Lehman ML; Nelson CC; Clements JA; Batra J
BMC Genomics; 2015 Dec; 16():1021. PubMed ID: 26626734
[TBL] [Abstract][Full Text] [Related]
17. Widespread splicing of repetitive element loci into coding regions of gene transcripts.
Darby MM; Leek JT; Langmead B; Yolken RH; Sabunciyan S
Hum Mol Genet; 2016 Nov; 25(22):4962-4982. PubMed ID: 28171598
[TBL] [Abstract][Full Text] [Related]
18. Novel kinase fusion transcripts found in endometrial cancer.
Tamura R; Yoshihara K; Yamawaki K; Suda K; Ishiguro T; Adachi S; Okuda S; Inoue I; Verhaak RG; Enomoto T
Sci Rep; 2015 Dec; 5():18657. PubMed ID: 26689674
[TBL] [Abstract][Full Text] [Related]
19. Panhandle PCR for cDNA: a rapid method for isolation of MLL fusion transcripts involving unknown partner genes.
Megonigal MD; Rappaport EF; Wilson RB; Jones DH; Whitlock JA; Ortega JA; Slater DJ; Nowell PC; Felix CA
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9597-602. PubMed ID: 10920186
[TBL] [Abstract][Full Text] [Related]
20. Disease-associated loci are significantly over-represented among genes bound by transcription factor 7-like 2 (TCF7L2) in vivo.
Zhao J; Schug J; Li M; Kaestner KH; Grant SF
Diabetologia; 2010 Nov; 53(11):2340-6. PubMed ID: 20640398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
